+96.7%
IWM vs MRNA
+786.4%
-689.6%
-41.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.9% | -2.2% | -0.7% | -2.8% |
| 7D | -7.5% | -12.7% | +5.2% | -6.9% |
| 30D | -7.2% | -20.7% | +13.5% | -6.3% |
| 3M | -13.6% | +46.3% | -59.8% | -15.5% |
| 6M | -7.9% | +305.2% | -313.1% | -18.7% |
| YTD | +5.0% | +561.2% | -556.3% | -11.5% |
| 1Y | +13.1% | +772.1% | -759.0% | -6.8% |
| 3Y | +47.9% | +147.0% | -99.0% | +30.5% |
| 5Y | +17.3% | -26.1% | +43.4% | +7.3% |
| All | +96.7% | +786.4% | -689.6% | +65.9% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling